[go: up one dir, main page]

DK0749304T4 - Retardtablet med et indhold af diclofenac-Na - Google Patents

Retardtablet med et indhold af diclofenac-Na

Info

Publication number
DK0749304T4
DK0749304T4 DK95913097T DK95913097T DK0749304T4 DK 0749304 T4 DK0749304 T4 DK 0749304T4 DK 95913097 T DK95913097 T DK 95913097T DK 95913097 T DK95913097 T DK 95913097T DK 0749304 T4 DK0749304 T4 DK 0749304T4
Authority
DK
Denmark
Prior art keywords
pct
tablet containing
containing diclofenac
date sep
retard tablet
Prior art date
Application number
DK95913097T
Other languages
English (en)
Other versions
DK0749304T3 (da
Inventor
Wilfried Fischer
Karin Klokkers
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6512563&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0749304(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of DK0749304T3 publication Critical patent/DK0749304T3/da
Application granted granted Critical
Publication of DK0749304T4 publication Critical patent/DK0749304T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK95913097T 1994-03-11 1995-03-13 Retardtablet med et indhold af diclofenac-Na DK0749304T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4408326A DE4408326A1 (de) 1994-03-11 1994-03-11 Retardtablette mit einem Gehalt an Diclofenac-Na
PCT/EP1995/000928 WO1995024188A1 (de) 1994-03-11 1995-03-13 Retardtablette mit einem gehalt an diclofenac-na

Publications (2)

Publication Number Publication Date
DK0749304T3 DK0749304T3 (da) 1999-08-02
DK0749304T4 true DK0749304T4 (da) 2004-03-29

Family

ID=6512563

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95913097T DK0749304T4 (da) 1994-03-11 1995-03-13 Retardtablet med et indhold af diclofenac-Na

Country Status (14)

Country Link
US (1) US5874107A (da)
EP (1) EP0749304B9 (da)
JP (1) JPH09509953A (da)
AT (1) ATE173399T1 (da)
AU (1) AU692534B2 (da)
CA (1) CA2185242C (da)
DE (2) DE4408326A1 (da)
DK (1) DK0749304T4 (da)
ES (1) ES2126265T5 (da)
FI (1) FI118294B (da)
GR (1) GR3029278T3 (da)
NO (1) NO317396B1 (da)
PL (1) PL177607B1 (da)
WO (1) WO1995024188A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
AU3860797A (en) * 1997-07-16 1999-02-10 Antrin Research Limited Pharmaceutical formulations for oral administration
JP4565456B2 (ja) * 1999-11-02 2010-10-20 塩野義製薬株式会社 着色顆粒の色素定着法
DE10029201A1 (de) 2000-06-19 2001-12-20 Basf Ag Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
AU2003225837B2 (en) * 2002-03-15 2008-11-06 Forest Laboratories Holdings Limited NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040228830A1 (en) * 2003-01-28 2004-11-18 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US8107531B2 (en) * 2003-09-07 2012-01-31 Microsoft Corporation Signaling and repeat padding for skip frames

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US5236713A (en) * 1987-10-21 1993-08-17 Teikoku Seiyaku Kabushiki Kaisha Preparation for intermittently releasing active agent applicable to oral cavity
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata

Also Published As

Publication number Publication date
AU692534B2 (en) 1998-06-11
DK0749304T3 (da) 1999-08-02
FI963567L (fi) 1996-09-10
NO317396B1 (no) 2004-10-25
EP0749304B2 (de) 2004-03-03
PL316196A1 (en) 1996-12-23
EP0749304A1 (de) 1996-12-27
FI118294B (fi) 2007-09-28
GR3029278T3 (en) 1999-05-28
JPH09509953A (ja) 1997-10-07
CA2185242A1 (en) 1995-09-14
EP0749304B1 (de) 1998-11-18
NO963796L (no) 1996-11-06
WO1995024188A1 (de) 1995-09-14
US5874107A (en) 1999-02-23
EP0749304B9 (de) 2006-03-08
DE4408326A1 (de) 1995-09-14
CA2185242C (en) 2004-11-23
AU2069595A (en) 1995-09-25
ES2126265T3 (es) 1999-03-16
NO963796D0 (no) 1996-09-10
FI963567A0 (fi) 1996-09-10
PL177607B1 (pl) 1999-12-31
ATE173399T1 (de) 1998-12-15
ES2126265T5 (es) 2004-10-16
DE59504270D1 (de) 1998-12-24

Similar Documents

Publication Publication Date Title
IT1276071B1 (it) Compositi ad attivita' anti-infiammatoria
TR200100931T2 (tr) Yeni sürekli salınımlı oral formülasyonlar
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
BR9407239A (pt) Azadioxacicloalquenos substituídos
FI962487A0 (fi) Rapamysiinijohdannaisia
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
SE9504661D0 (sv) New compounds
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
FI970147A0 (fi) Triatsoliyhdisteitä ja niiden käyttö dopamiini-D3-ligandeina
PT749308E (pt) Pastilha, revestida com filme, de paracetamol e domperidona
DK0749304T3 (da) Retardtablet med et indhold af diclofenac-Na
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
US5690869C1 (en) Use of a polymer material on the basis of modified hydrocolloids as covering material
FR2718020B1 (fr) Composition galénique mucoadhésive hétérofonctionnelle.
BR9609847A (pt) Derivados de N-(4-Benzila-substituída)-2-aminolactam
DE69102704D1 (de) Orales, melatonin enthaltendes arzneimittel.
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
DK0701449T3 (da) Fremgangsmåde til fremstilling af en oral fast dosisform indeholdende diclofenac
ATE179164T1 (de) Hiv-proteaseinhibitoren
ATE215084T1 (de) Imidazopyridin-azolidinone
PL320198A1 (en) Children-safe active substance plaster package
DE69526584D1 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
DK0742716T3 (da) Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid
ATE207480T1 (de) Substituierte aminoalkylaminopyridine
SE9404438D0 (sv) New process